Get this report today!
Table of Contents
Within the global pharmaceutical industry, protein therapeutics has been enjoying the fastest growth for the past few years. Playing a significant role in the treatment of many major diseases, protein therapies have revolutionized the methodology followed by drugs. These therapies owe their high efficiency to their targeted approach, which avoids side effects on healthy organs to a great extent. The acceptance of the various protein therapies can be attributed to the increasing prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and rising penetration of medical insurance.
According to our new research report “Global Protein Therapeutics Market Analysis”, the global protein therapeutics market is expected to grow at a CAGR of around 13% during 2012-2014. Various factors, such as introduction of new protein therapeutics and enhanced investments will contribute to the buoyant growth of this industry. Besides, augmentation in the number of clinical trials will surface the optimistic performance of the industry.
Based on our in-depth analysis of the industry, we have identified the major segments in protein therapeutics market, which include Monoclonal antibody, Insulin, Interferon, G-CSF, coagulation factors etc. Amongst the segments, monoclonal antibody dominates the global protein therapeutics market and is expected to be at the top in future as well. This has been possible due to the large numbers of players that have been directing their efforts to develop innovative treatments using mAbs.
As per our research, fast growth in protein therapeutics will also strengthen other emerging sectors. Bio-generics will represent a key future growth segment as it will try to offset the loss of market revenue as a result of patent expirations of branded therapies. Additionally, the market trends studied in the report suggest that, a lot of research work in the segment would be targeting the immunogenicity issues related to the protein therapies.
The report provides extensive information and rational analysis of the global protein therapeutics market. It has thoroughly examined current market trends, industrial developments, and competitive landscape to enable clients understands the market structure and its progress in coming years. The forecasts presented in the report are based on the correlation between the market trends and drivers.
Talk to Alison
+1 718 618 4897
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Market Opportunities for Differentiated Therapeutics Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a ...
Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors ...
Emerging Technology and Major Partnerships in Influenza Vaccines Influenza is a burgeoning problem across the entire globe, there is an increased need for new therapeutic methods. A whole host of technology ...
... Treatments, pipelines, and commercial opportunities, spectra intelligence, april 2006, pages: 369 2--melanoma therapeutics - pipeline assessment and market forecasts to 2019, globaldata 3--american cancer ...
... In 2011, of the total pain management therapeutics market by therapeutic class. This class comprises of some of the oldest known painkillers such as diclofenac, ibuprofen and aspirin (acetylsalicylic acid ...
... Medicine: definition 2 The tailoring of medical treatment to the specific characteristics of each patient. [It] does not literally mean the creation of drugs or medical devices that are unique ...
Reportlinker.com © Copyright 2013. All rights reserved.